Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Upward trend in financing continues, but fewer feel flush

Article Abstract:

Biotech financing has totaled about $27 billion in 2006, where most of the increase has come from exceptionally large debt deals. The shift from initial public offering (IPO) to merger and acquisition (M&A) has increased and the year 2006 has turned out to be the biggest year for biotech venture capital (VC) investment with $5.5 billion by early December.

Author: Lawrence, Stacy
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Financial report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Patent drop reveals pressures on industry

Article Abstract:

Increasing pressure for clearly defined patent applications, the completion of the human genome project and the 2000 biotech market bubble could be behind the shrinking number of biotech patents approved in the United States. The trend seems to have declined in 2004 with DNA-based patent applications down 23 percent for the first half of the year.

Author: Lawrence, Stacy
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Methods, Analysis, DNA-ligand interactions, DNA binding, Human genome

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Looking at US versus European exit opportunities

Article Abstract:

The data on initial public offerings (IPOs) and trade sale exits through mergers and acquisitions (M&A) suggest that the exit opportunities for biotech investors and entrepreneurs are in greater supply in the US than in Europe. The data reveals that the proceeds and volume for biotech IPOs in the US actually peaked in the second quarter of 2004.

Author: Lawrence, Stacy
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Europe, Financial management, Finance, Going public (Securities), Initial public offerings, Company public offering, Company financing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Biotechnology industry, Biotechnology industries, Forecasts and trends, Market trend/market analysis, Securities, Company securities
Similar abstracts:
  • Abstracts: Investor warning. Taming the beast: The tax consolidation regime is a complex beast, but the ICAA is helping members confront it head on. Here's how
  • Abstracts: Choice of business entity after the 2003 tax act. Taking a Subchapter T Cooperative Public. Tangible guidance on intangibility
  • Abstracts: Consumer online privacy concerns and responses: a power - responsibility equilibrium perspective. Consumer cheating on service guarantees
  • Abstracts: Client expense accounting becomes more complex. Tax aspects of working at home. Charging clients: find the best method to suit your needs - part II.
  • Abstracts: Postural perturbation and muscular response following sudden release during symmetric squat and stoop lifting
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.